Medanta Gurugram, ranked India’s Best Private Hospital by Newsweek for six consecutive years, has showcased its innovation-led growth as Dr. Ashok Rajgopal, Group Chairman – Medanta Institute of Musculoskeletal Disorders and Orthopaedics, completed 40,000 knee replacement surgeries. The milestone reflects how Medanta is leveraging cutting-edge technology, robotics, and patient-centric models—principles often associated with startups—to disrupt traditional healthcare delivery.
India’s knee replacement market is on a fast-growth trajectory, projected to expand at an 11% CAGR from 2025–2035. Cases of osteoarthritis are expected to hit 60 million by 2025, creating a growing consumer base seeking minimally invasive solutions, faster recovery, and personalized implants. Dr. Rajgopal emphasized the role of robotic-assisted surgeries and structured rehabilitation in transforming outcomes.
The appetite for innovative healthcare solutions is evident as patients in Meghalaya increasingly seek access to advanced orthopaedic care. However, many still travel to Guwahati or Delhi for treatment, highlighting a gap ripe for disruption. Medanta’s expansion into the Northeast is expected to reshape this market, offering patients access to next-gen surgical innovations closer to home. With its startup-like focus on innovation and scalability, Medanta continues to redefine India’s healthcare growth story.
